--- title: "Odyssey Therapeutics (ODTX) news: IPO and offering" url: "https://aibio.space/companies/odyssey-therapeutics/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ODTX IPO and offering news: Odyssey Therapeutics files for IPO, plans Nasdaq Capital Market listing as ODTX. Odyssey Therapeutics, Inc." --- ODTX Odyssey Therapeutics, Inc. NASDAQ · United States # Odyssey Therapeutics (ODTX) news ODTX IPO and offering news Financings · 2026-05-11 ## [Odyssey Therapeutics sells 1,388,889 shares to TPG affiliate at $18.00 in private placement](https://aibio.space/news/odyssey-therapeutics-sells-1-388-889-shares-tpg-affiliate-18-00/) The private placement closed alongside Odyssey's initial public offering. The Share Purchase Agreement is dated May 7, 2026 and names five placement agents. ## Latest Odyssey Therapeutics news 1. 2026-04-17 Financings [Odyssey Therapeutics files for IPO, plans Nasdaq Capital Market listing as ODTX](https://aibio.space/news/odyssey-therapeutics-files-ipo-plans-nasdaq-capital-market-listing/) Odyssey Therapeutics, Inc. filed a Form S-1 on April 17, 2026. The cover leaves the share count and price range blank. ## Odyssey Therapeutics at a glance - **Ticker**: ODTX - **Listing**: NASDAQ - **Country**: United States ### Related companies - [Jasper Therapeutics](https://aibio.space/companies/jasper-therapeutics/) NASDAQ: JSPR - [Exicure](https://aibio.space/companies/exicure/) NASDAQ: XCUR - [Kailera Therapeutics](https://aibio.space/companies/kailera-therapeutics/) NASDAQ: KLRA - [Armata Pharmaceuticals](https://aibio.space/companies/armata-pharmaceuticals/) AMEX: ARMP - [Voyager Therapeutics](https://aibio.space/companies/voyager-therapeutics/) NASDAQ: VYGR - [Zura Bio](https://aibio.space/companies/zura-bio/) NASDAQ: ZURA - [Champions Oncology](https://aibio.space/companies/champions-oncology/) NASDAQ: CSBR - [Neutra](https://aibio.space/companies/neutra/) OTC: NTRR ### Also on NASDAQ - [YD Bio](https://aibio.space/companies/yd-bio/) YDES - [Zymeworks](https://aibio.space/companies/zymeworks/) ZYME - [Lyell Immunopharma](https://aibio.space/companies/lyell-immunopharma/) LYEL - [Evolus](https://aibio.space/companies/evolus/) EOLS - [NewcelX](https://aibio.space/companies/newcelx/) NCEL - [Alaunos Therapeutics](https://aibio.space/companies/alaunos-therapeutics/) TCRT ## Questions about Odyssey Therapeutics When did Odyssey Therapeutics go public? Our latest story on this, dated Apr 17, 2026: "Odyssey Therapeutics files for IPO, plans Nasdaq Capital Market listing as ODTX". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/odyssey-therapeutics-files-ipo-plans-nasdaq-capital-market-listing/). Has Odyssey Therapeutics raised money recently? Our latest story on this, dated May 11, 2026: "Odyssey Therapeutics sells 1,388,889 shares to TPG affiliate at $18.00 in private placement". The story links the filing or release it is based on. [Read the story](https://aibio.space/news/odyssey-therapeutics-sells-1-388-889-shares-tpg-affiliate-18-00/). What is the ticker symbol of Odyssey Therapeutics? Odyssey Therapeutics, Inc. trades under the ticker ODTX on NASDAQ. Where is Odyssey Therapeutics listed? Odyssey Therapeutics, Inc. is listed on NASDAQ. What is the SEC CIK of Odyssey Therapeutics? The SEC Central Index Key (CIK) for Odyssey Therapeutics, Inc. is 1882782. Its filings are on SEC EDGAR. How many shares does Odyssey Therapeutics have outstanding? 48,058,527 shares as of 2026-08-03, per the cover page of its 10-Q filed 2026-08-06. Which country or territory is Odyssey Therapeutics listed under? Our directory records Odyssey Therapeutics, Inc. under United States. What does Odyssey Therapeutics do? Our directory classifies Odyssey Therapeutics, Inc. as: Biotechnology. This is a directory classification, not a description of the pipeline. What is the ISIN of Odyssey Therapeutics? The ISIN recorded for Odyssey Therapeutics, Inc. is US67613T1043. Does aibio.space cover Odyssey Therapeutics? aibio.space lists Odyssey Therapeutics, Inc. among 2,820 public biotech companies and publishes its news here as stories appear. Where is Odyssey Therapeutics incorporated? SEC records list its state or country of incorporation as DE. What is the latest Odyssey Therapeutics (ODTX) stock news? Our latest story on Odyssey Therapeutics, dated May 11, 2026: "Odyssey Therapeutics sells 1,388,889 shares to TPG affiliate at $18.00 in private placement". The private placement closed alongside Odyssey's initial public offering. The Share Purchase Agreement is dated May 7, 2026 and names five placement agents. [Source](https://aibio.space/news/odyssey-therapeutics-sells-1-388-889-shares-tpg-affiliate-18-00/). How long will Odyssey Therapeutics's cash last? From our story of Apr 17, 2026: The audited statements carry a going-concern warning. [Source](https://aibio.space/news/odyssey-therapeutics-files-ipo-plans-nasdaq-capital-market-listing/). Is Odyssey Therapeutics a smaller reporting company? SEC records list Odyssey Therapeutics, Inc.'s filer category as:
Emerging growth company. Where is Odyssey Therapeutics headquartered? SEC records list its business address as 51 SLEEPER STREET, BOSTON, MA, 02210. ## Investor discussion: Odyssey Therapeutics Members talk about Odyssey Therapeutics (ODTX). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Odyssey Therapeutics, newest first. Each line links the filing it comes from. 1. 2026-06-23 Financings Reported a financing. SEC Form 8-K (Items 7.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1882782/000119312526278581/odtx-ex99_1.htm) 2. 2026-05-08 Financings Reported a financing. SEC Form 424B4. [Source](https://www.sec.gov/Archives/edgar/data/1882782/000119312526214819/odyssey__form_424b4.htm) 3. 2026-04-17 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/1882782/000119312526161514/odtx-20260417.htm) 4. 2025-01-17 Financings Filed a registration statement for a share offering. SEC Form S-1. [Source](https://www.sec.gov/Archives/edgar/data/1882782/000119312525008362/d818486ds1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:ODTX on TradingView](https://www.tradingview.com/symbols/NASDAQ-ODTX/). ## SEC filings and registration - **SEC name**: Odyssey Therapeutics, Inc. - **CIK**: 1882782 - **Industry (SIC)**: Biological Products, (No Diagnostic Substances) (2836) - **US tickers**: ODTX (Nasdaq) - **State or country of incorporation**: DE - **Fiscal year ends**: December 31 - **Filer category**:
Emerging growth company - **Business address**: 51 SLEEPER STREET, BOSTON, MA, 02210 - **Phone**: (212) 841-1000 - **Shares outstanding**: 48,058,527 as of 2026-08-03 (10-Q filed 2026-08-06) ### Recent filings (8-K and 6-K are the company's own announcements) - [8-K](https://www.sec.gov/Archives/edgar/data/1882782/000119312526425684/odtx-20261020.htm) filed 2026-10-20 - [8-K](https://www.sec.gov/Archives/edgar/data/1882782/000119312526385477/odtx-20260908.htm) filed 2026-09-09 - [10-Q](https://www.sec.gov/Archives/edgar/data/1882782/000119312526335822/odtx-20260630.htm) filed 2026-08-06 - [8-K](https://www.sec.gov/Archives/edgar/data/1882782/000119312526331512/odtx-20260804.htm) filed 2026-08-04 - [8-K](https://www.sec.gov/Archives/edgar/data/1882782/000119312526278581/odtx-20260623.htm) filed 2026-06-23 - [10-Q](https://www.sec.gov/Archives/edgar/data/1882782/000119312526274290/odtx-20260331.htm) filed 2026-06-17 - [8-K](https://www.sec.gov/Archives/edgar/data/1882782/000119312526274291/odtx-20260617.htm) filed 2026-06-17 - [8-K](https://www.sec.gov/Archives/edgar/data/1882782/000119312526216899/odtx-20260507.htm) filed 2026-05-11 Source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001882782), retrieved October 23, 2026. Shares outstanding is the cover-page figure from the latest periodic report. The SEC does not publish share prices. ## Listing details Odyssey Therapeutics, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ODTX, recorded under United States. The directory classifies it as Biotechnology. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Odyssey Therapeutics, Inc. - **Ticker**: ODTX - **Listing**: NASDAQ - **Country or territory**: United States - **Business scope**: Biotechnology - **ISIN**: US67613T1043 - **Last quote in directory**: 2026-10-21 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/NASDAQ-ODTX/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/odyssey-therapeutics/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Odyssey Therapeutics (ODTX) news: IPO and offering", 2026-10-31, https://aibio.space/companies/odyssey-therapeutics/